Apoptosis
Los inhibidores de la apoptosis son compuestos que previenen o retrasan el proceso de muerte celular programada, conocido como apoptosis. Estos inhibidores son vitales para estudiar los mecanismos de supervivencia celular y se utilizan para investigar enfermedades donde la apoptosis está desregulada, como el cáncer, los trastornos neurodegenerativos y las enfermedades autoinmunes. Al modular la apoptosis, estos inhibidores pueden ayudar en el desarrollo de terapias dirigidas a controlar la muerte celular. En CymitQuimica, ofrecemos una amplia selección de inhibidores de la apoptosis de alta calidad para apoyar su investigación en biología celular, oncología y campos relacionados.
Subcategorías de "Apoptosis"
- ASK(6 productos)
- BCL(11 productos)
- Caspasa(125 productos)
- FOXO1(3 productos)
- IAP(66 productos)
- Mdm2(12 productos)
- PD-1 / PD-L1(125 productos)
- PDK(9 productos)
- PERK(25 productos)
- Serina / treonina quinasa(15 productos)
- Survivin(13 productos)
- TNF(92 productos)
- c-RET(51 productos)
- p53(62 productos)
Mostrar 6 subcategorías más
Se han encontrado 5600 productos de "Apoptosis"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Vin-C01
CAS:<p>Vin-C01, a potent protector of pancreatic β-cells (EC50=0.22μM), aids in type 2 diabetes research by preventing STZ-induced β-cell apoptosis.</p>Fórmula:C20H24N2OForma y color:SolidPeso molecular:308.42bpV(phen)
CAS:<p>bpV(phen) is a potent protein tyrosine phosphatase (PTP) and PTEN inhibitor (IC50s: 343 nM, 920 nM, and 38 nM for PTP-β, PTP-1B, and PTEN).</p>Fórmula:C12H8KN2O5VPureza:98%Forma y color:SolidPeso molecular:350.24Epofolate
CAS:<p>Epofolate: folate receptor-targeted antimitotic, delivers epothilone to cancer cells, inhibits mitosis, may halt tumor growth. Check clinical trials.</p>Fórmula:C67H92N16O22S3Forma y color:SolidPeso molecular:1569.74TrxR inhibitor D9
CAS:<p>TrxR-IN-D9 is a novel inhibitor of thioredoxin reductase (TrxR).</p>Fórmula:C25H20AuOPSForma y color:SolidPeso molecular:596.43p53 Activator 2
CAS:<p>p53 Activator 2 binds to DNA, breaks it, halts cell cycle at G2/M, triggers apoptosis, reduces Bcl-2/Bcl-xL, IC50: 1.73μM against MGC-803.</p>Fórmula:C20H21N5O2Forma y color:SolidPeso molecular:363.41Simmiparib
CAS:<p>Simmiparib (SMOCL-9112) is a PARP1 and PARP2 inhibitor that promotes apoptosis.Simmiparib is used to study Parkinson's disease and melanoma.</p>Fórmula:C23H18F4N6O2Pureza:99.05% - 99.51%Forma y color:SolidPeso molecular:486.42MIR002
CAS:<p>MIR002: an oral POLA1/HDAC11 inhibitor with antitumor effects, enhances p53/p21, causes G1/S arrest, and triggers apoptosis.</p>Fórmula:C27H29NO5Forma y color:SolidPeso molecular:447.52cRIPGBM
CAS:<p>cRIPGBM induces apoptosis in GBM CSCs by targeting RIPK2, with an EC50 of 68 nM in GBM-1 cells.</p>Fórmula:C26H20FN2O2Pureza:98%Forma y color:SolidPeso molecular:411.45DPBQ
CAS:<p>DPBQ (ZINC1620467) is a p53 activator.</p>Fórmula:C24H14N2O2Pureza:98.08%Forma y color:SolidPeso molecular:362.38QTX125
CAS:<p>QTX125: potent, selective HDAC6 inhibitor with strong antitumor effects.</p>Fórmula:C23H19N3O5Forma y color:SolidPeso molecular:417.41BS-181
CAS:<p>BS-181 is a highly selective CDK7 inhibitor (IC50: 21 nM); >40-fold selective for CDK7 than CDK1/2/4/5/6/9.</p>Fórmula:C22H32N6Pureza:98%Forma y color:SolidPeso molecular:380.53Topoisomerase II inhibitor 7
CAS:<p>Topoisomerase II inhibitor 7 halts cell division and induces apoptosis, targeting topoisomerase II alpha with a 3.19 μM IC50.</p>Fórmula:C32H28BrN5O5SForma y color:SolidPeso molecular:674.56HJC0416
CAS:<p>HJC0416 is a potent orally bioavailable signal transducer and activator of transcription 3 inhibitor.</p>Fórmula:C18H17ClN2O4SPureza:98%Forma y color:SolidPeso molecular:392.86ATX inhibitor 13
CAS:<p>ATX inhibitor 13: orally active, IC50 3.4 nM, halts RAW264.7 cells at G2, curbs growth/migration, prompts apoptosis, suppresses tumors.</p>Fórmula:C31H35Cl2N5O3Forma y color:SolidPeso molecular:596.55SAR125844
CAS:<p>SAR125844, a potent and highly selective inhibitor of the MET receptor tyrosine kinase (RTK), for intravenous administration. (IC50 value of 4.2 nmol/L)</p>Fórmula:C25H23FN8O2S2Pureza:98.73%Forma y color:SolidPeso molecular:550.63VRT-043198
CAS:<p>VRT-043198, a VX-765 metabolite, is a potent ICE/caspase-1 inhibitor, crossing the blood-brain barrier with K i of 0.8/0.6 nM.</p>Fórmula:C22H29ClN4O6Forma y color:SolidPeso molecular:480.94Aurora kinase-IN-1
<p>Aurora kinase-IN-1: potent aurora kinase inhibitor, alters G1 cycle proteins, induces G1/S arrest and apoptosis, potential chemotherapy lead.</p>Fórmula:C30H25Br2N3O5Forma y color:SolidPeso molecular:667.34CMLD012072
CAS:<p>CMLD012072 is a potent eukaryotic initiation factor 4A (eIF4A) inhibitor with potent anti-neoplastic activity. It can induce RNA clamping of eIF4A1 and eIF4A2.</p>Fórmula:C32H32N2O7Pureza:98%Forma y color:SolidPeso molecular:556.61AG6033
CAS:<p>AG6033, a novel CRBN modulator, degrades GSPT1/IKZF1 and inhibits various tumors.</p>Fórmula:C30H23N5O4Forma y color:SolidPeso molecular:517.53HDAC-IN-31
CAS:<p>HDAC-IN-31: Oral HDAC inhibitor; targets HDAC1, 2, 3; weak on HDAC8; potential in fighting lymphoma.</p>Fórmula:C25H24N4O2Forma y color:SolidPeso molecular:412.48RIPK1-IN-15
CAS:<p>RIPK1-IN-15 (Compound 2.5) is a potent RIPK1 inhibitor that has the potential in neurodegenerative, autoimmune, and inflammatory diseases research [1].</p>Fórmula:C19H19N3O2Forma y color:SolidPeso molecular:321.37Verrucarin J
CAS:<p>Verrucarin J, a Myrothecium fungus metabolite, triggers apoptosis in some cancer cells and fights Candida, Mucor, and JUNV (IC50: 1.2 ng/mL).</p>Fórmula:C27H32O8Forma y color:SolidPeso molecular:484.54Lemuteporfin
CAS:<p>Lemuteporfin is a light-activated photosensitizing agent confers cytotoxic upon light activation.reduce sebaceous gland volume in animal studies.</p>Fórmula:C44H48N4O10Pureza:97.14% - 99.44%Forma y color:SolidPeso molecular:792.87BTK-IN-24
CAS:<p>BTK-IN-24 is a Bruton's tyrosine kinase (BTK) inhibitor with potential anticancer activity, and it can be used in the study of myeloproliferative disorders.</p>Fórmula:C26H19F4N5O2Pureza:99.61%Forma y color:SolidPeso molecular:509.46AFG206
CAS:AFG206 is the novel first-generation type II" FLT3 inhibitor."Fórmula:C20H19N3O2Forma y color:SolidPeso molecular:333.38PARP-1-IN-2
CAS:<p>PARP-1-IN-2 is a potent PARP1 inhibitor that crosses the blood-brain barrier (IC50: 149 nM).PARP-1-IN-2 showed significant antiproliferative activity against</p>Fórmula:C22H15Cl2N3O2Pureza:98.82%Forma y color:SolidPeso molecular:424.28(S)-PERK-IN-5
CAS:<p>(S)-PERK-IN-5 is the S-enantiomer of PERK-IN-5. (S)-PERK-IN-5 is a PERK inhibitor (IC50: 0.101-0.250 μM).</p>Fórmula:C25H26F2N4O3Forma y color:SolidPeso molecular:468.5MI-3
CAS:<p>MI-3 (Menin-MLL Inhibitor) (Menin-MLL Inhibitor) is an effective inhibitor of Menin-MLL interaction (IC50: 648 nM).</p>Fórmula:C18H25N5S2Pureza:98.66% - 99.61%Forma y color:SolidPeso molecular:375.55Se-Methylselenocysteine hydrochloride
CAS:<p>Se-Methylselenocysteine hydrochloride, a precursor to Methylselenol, exhibits significant cancer chemopreventive and antioxidant activities.</p>Fórmula:C4H10ClNO2SePureza:98%Forma y color:SolidPeso molecular:218.54AP1867
CAS:<p>AP1867 is a synthetic FKBP12F36V-directed ligand.</p>Fórmula:C38H47NO11Forma y color:SolidPeso molecular:693.78p53 Activator 5
CAS:<p>Potent p53 Activator 5, SC150 <0.05 mM, restores mutant p53 DNA binding, exhibits anti-tumor properties.</p>Fórmula:C29H32F6N4OForma y color:SolidPeso molecular:566.58LY5
CAS:<p>LY5 is an inhibitor of STAT3 that acts by inhibiting cell viability, cell migration, and angiogenesis in medulloblastoma cells.</p>Fórmula:C15H11N3O4SPureza:98%Forma y color:SolidPeso molecular:329.33Erbstatin
CAS:<p>Erbstatin is a tyrosine-protein kinase inhibitor. When combined with foroxymithine, it has antineoplastic activity against L-1210 leukemia.</p>Fórmula:C9H9NO3Forma y color:SolidPeso molecular:179.17IHMT-TRK-284
CAS:<p>IHMT-TRK-284: Oral type II TRK inhibitor; targets TRKA, TRKB, TRKC (IC50s: 10.5, 0.7, 2.6 nM); selective and anti-tumor effective.</p>Fórmula:C25H27N7OSForma y color:SolidPeso molecular:473.59BI-0282
CAS:<p>BI-0282 (Compound 1) is a potent inhibitor of the MDM2-p53 interaction.</p>Fórmula:C30H23Cl2FN4O4Forma y color:SolidPeso molecular:593.43PI3K/Akt/mTOR-IN-3
CAS:<p>PI3K/Akt/mTOR-IN-3 is a powerful inhibitor, halting MCF-7, HeLa, and HepG2 cell migration and triggering S phase arrest and apoptosis.</p>Fórmula:C34H51NO2Forma y color:SolidPeso molecular:505.77Bcl-2/Mcl-1-IN-2
CAS:<p>Bcl-2/Mcl-1-IN-2 is a Bcl-2 (Ki: 4.70 μM) and Mcl-1 (Ki: 0.88 μM) inhibitor.Bcl-2/Mcl-1-IN-2 can be used in cancer research.</p>Fórmula:C26H24ClNO3Forma y color:SolidPeso molecular:433.93AV123
CAS:AV123, a RIPK1 inhibitor, non-cytotoxic, IC50: 12.12 μM; blocks TNF-α necroptosis (EC50: 1.7 μM) not apoptosis; useful in necrosis-related disease studies.Fórmula:C11H14N4O2Forma y color:SolidPeso molecular:234.25CRA-026440
CAS:<p>CRA-026440(PCI-34051) is a highly potent HDAC inhibitor with inhibitory effects on HDAC1, HDAC2, HDAC3, HDAC6, HDAC8 and HDAC10 with Ki values of 4,14,11,15,7</p>Fórmula:C23H24N4O4Pureza:96.42%Forma y color:SolidPeso molecular:420.46Didesmethylrocaglamide
CAS:<p>Didesmethylrocaglamide, a Rocaglamide derivative, is a potent eukaryotic initiation factor 4A (eIF4A) inhibitor that exhibits strong growth-inhibitory effects,</p>Fórmula:C27H27NO7Forma y color:SolidPeso molecular:477.51Semapimod
CAS:<p>Semapimod is an inhibitor of proinflammatory cytokine production, capable of suppressing TNF-α, IL-1β, and IL-6.</p>Fórmula:C34H52N18O2Forma y color:SolidPeso molecular:744.9VMY-1-103
CAS:<p>VMY-1-103: a strong CDK inhibitor better than purvalanol B; halts prostate/breast cancer cell growth, induces apoptosis, may treat medulloblastoma.</p>Fórmula:C34H42ClN9O4SForma y color:SolidPeso molecular:708.27PDK4-IN-1
CAS:<p>PDK4-IN-1 is an anthraquinone derivative and a potent and orally active inhibitor of pyruvate dehydrogenase kinase 4 (PDK4)(IC50 value of 84 nM).</p>Fórmula:C22H19N3O2Pureza:98%Forma y color:SolidPeso molecular:357.41IST5-002
CAS:<p>IST5-002: Potent Stat5a/b blocker, IC50 1.5μM/3.5μM, targets prostate cancer & CML.</p>Fórmula:C17H20N5O7PPureza:99.36%Forma y color:SolidPeso molecular:437.34MI-192
CAS:<p>MI-192: Selective HDAC2/3 inhibitor, IC50=30/16 nM, induces apoptosis in myeloid leukemia, potential in leukemia/anti-stroke treatment.</p>Fórmula:C24H21N3O2Forma y color:SolidPeso molecular:383.44Anticancer agent 83
CAS:<p>Anticancer agent 83: potent, GI50 0.15 mM against LOX IMVI, reduces mitochondria potential, DNA damage, induces leukemia apoptosis.</p>Fórmula:C20H19N5OSForma y color:SolidPeso molecular:377.46c-Met-IN-14
CAS:<p>c-Met-IN-14: selective c-Met kinase inhibitor, IC50 2.89 nM, anticancer, stops G2/M phase, induces A549 cell apoptosis.</p>Fórmula:C34H38ClFN4O7SForma y color:SolidPeso molecular:701.2DRAK2-IN-1
CAS:<p>Drak2-in-1: ATP-competitive DRAK2 inhibitor; IC50 = 3 nM, KI = 0.26 nM; affects DRAK1 (IC50 = 51 nM).</p>Fórmula:C21H20N4O3Forma y color:SolidPeso molecular:376.41LSD1-IN-14
CAS:<p>LSD1-IN-14: potent LSD1 inhibitor, IC50 0.89 μM; hinders A549/THP-1 cell growth, induces tumor cell apoptosis.</p>Fórmula:C21H24FN5Forma y color:SolidPeso molecular:365.45LLP-3
CAS:<p>Survivin inhibitor LLP-3 induces apoptosis in glioma cells by blocking Ran interaction; halts glioblastoma growth. IC50 = 31 μM.</p>Fórmula:C32H23ClN2O4Forma y color:SolidPeso molecular:534.99GRI977143
CAS:<p>GRI977143: selective LPA2 agonist (EC50=3.3μM), blocks caspases 3/7/8/9, limits DNA fragmentation.</p>Fórmula:C22H17NO4SPureza:98.07%Forma y color:SolidPeso molecular:391.44NKP-1339
CAS:<p>NKP-1339 (IT-139) induces G2/M cell cycle arrest, blockage of DNA synthesis, and induction of apoptosis via the mitochondrial pathway.</p>Fórmula:C14H12Cl4N4NaRuPureza:98%Forma y color:SolidPeso molecular:502.14Flonoltinib
CAS:<p>Flonoltinib (JAK2/FLT3-IN-1) is an orally active and efficient JAK2/FLT3 inhibitor with anti-cancer properties.</p>Fórmula:C25H34FN7OPureza:99.52%Forma y color:SolidPeso molecular:467.58BR102375
CAS:<p>BR102375 is a non-TZD PPAR γ full agonist (EC50: 0.28 μM) for the treatment of type 2 diabetes.</p>Fórmula:C31H34N6O4Pureza:98%Forma y color:SolidPeso molecular:554.64Antitumor agent-44
CAS:<p>Antitumor agent-44 (Compound 5n) elicits potent antitumor effects by inducing disruption of mitochondrial homeostasis, cell cycle arrest, and apoptosis in human</p>Fórmula:C24H15N3O3Forma y color:SolidPeso molecular:393.39Antitumor agent-62
CAS:<p>Antitumor agent-62 releases NO, inhibits cancer cell growth, triggers apoptosis, and halts cell cycle at G2/M.</p>Fórmula:C21H19N3O9SForma y color:SolidPeso molecular:489.46Antioxidant agent-5
CAS:<p>Antioxidant agent-5 (D-6) curbs oxLDL effects, ROS, NF-κB movement, apoptosis in VECs; boosts Nrf2/HO-1; protects endothelium.</p>Fórmula:C24H24N6OForma y color:SolidPeso molecular:412.49ZT55
CAS:<p>ZT55: Oral JAK2 inhibitor, IC50: 0.031 μM, hinders JAK2 V617F HEL cell growth, induces apoptosis, arrests cell cycle, effective in mice HEL tumor studies.</p>Fórmula:C17H16N2O3Forma y color:SolidPeso molecular:296.32RET-IN-12
CAS:<p>RET-IN-12 is a RET inhibitor capable of acting on RET(WT) (IC50: 0.3 nM) and RET(V804M) (IC50: 1 nM).</p>Fórmula:C30H30F3N5O4Forma y color:SolidPeso molecular:581.59PDE5/HDAC-IN-1
CAS:<p>PDE5/HDAC-IN-1 is a potent inhibitor of phosphodiesterase 5 (PDE5) and HDAC, with IC50 values of 46.3 nM and 14.5 nM, respectively.</p>Fórmula:C27H29BrN4O4Forma y color:SolidPeso molecular:553.45Tubulin inhibitor 33
CAS:<p>Tubulin Inhibitor 33 is a dose-dependent inhibitor of tubulin polymerization, exhibiting an IC50 value of 9.05 μM.</p>Fórmula:C24H22N4O3Forma y color:SolidPeso molecular:414.46Tezacitabine
CAS:<p>Tezacitabine, a nucleoside analogue, inhibits ribonucleotide reductase, disrupts DNA replication, and induces apoptosis in tumor cells.</p>Fórmula:C10H12FN3O4Forma y color:SolidPeso molecular:257.22EGFR-IN-60
CAS:<p>EGFR-IN-60: oral anticancer drug, inhibits EGFR/JAK3, effective on H1975/A431 cells, promotes apoptosis.</p>Fórmula:C28H28Cl2N6OForma y color:SolidPeso molecular:535.47RIPK1-IN-12
CAS:<p>RIPK1-IN-12: Strong RIPK1 blocker, hinders necroptosis; EC50=1.6 nM (human), 2.9 nM (mouse).</p>Fórmula:C24H26N4O3SForma y color:SolidPeso molecular:450.55Alteminostat
CAS:<p>Alteminostat is used as a histone deacetylase inhibitor and is an antineoplastic drug candidate.</p>Fórmula:C27H36N6O3Forma y color:SolidPeso molecular:492.61Apoptotic agent-2
CAS:<p>Apoptotic agent-2 reduces Bcl-2, boosts Bax & caspase-3, inducing apoptosis for cancer research.</p>Fórmula:C25H16ClN7SForma y color:SolidPeso molecular:481.96Ceranib-2
CAS:<p>Ceranib-2, a ceramidase inhibitor (IC50: 28 μM, SKOV3), reduces sphingosine/S1P and promotes apoptosis, showing anticancer properties.</p>Fórmula:C25H19NO3Pureza:98.49%Forma y color:SolidPeso molecular:381.42Topoisomerase II inhibitor 10
CAS:<p>Topoisomerase II inhibitor 10 is a potent inhibitor of topoisomerase II (IC50: 7.45 μM).</p>Fórmula:C27H20N6O7SForma y color:SolidPeso molecular:572.55Apoptosis inducer 8
CAS:<p>Apoptosis inducer 8 is a galectin-1 (gal-1)-mediated apoptosis inducer and a PET imaging agent that significantly reduces gal-1 protein levels and can be used</p>Fórmula:C29H22ClN5O2Forma y color:SolidPeso molecular:507.97MMPSI
CAS:<p>MMPSI (Caspase-3/7 Inhibitor I) is a caspase 3 and caspase 7 inhibitor that inhibits ischemic injury in cardiomyocytes and can be used to study cardioprotection</p>Fórmula:C14H16N2O5SPureza:99.74%Forma y color:SolidPeso molecular:324.35(5Z,2E)-CU-3
CAS:<p>(5Z,2E)-CU-3 is a potent and selective inhibitor of DGKα isozyme with an IC50 value of 0.6 μM and inhibition of DGKα by competing ATP with a Km value of 0.48 mM</p>Fórmula:C16H12N2O4S3Pureza:99.02%Forma y color:SolidPeso molecular:392.47USP7-IN-4
CAS:<p>USP7-IN-4 is a non-competitive, potent and selective inhibitor of USP7, up-regulates p53 and p21, down-regulates MDM2,anti-proliferativity RS4;11 (leukemia) .</p>Fórmula:C29H34N6O3Pureza:98.27% - 99.09%Forma y color:SolidPeso molecular:514.62APPA
CAS:<p>APPA, an aldose reductase inhibitor, demonstrates efficacy in preventing apoptosis and symptoms of Streptozotocin-induced diabetes in rats through inhibition of</p>Fórmula:C14H13NO3Pureza:98%Forma y color:SolidPeso molecular:243.26D-Cl-amidine
CAS:<p>D-Cl-amidine is an effective and highly selective PAD1 inhibitor. D-Cl-amidine has a good correlation and no obvious toxicity.</p>Fórmula:C14H19ClN4O2Pureza:98%Forma y color:SolidPeso molecular:310.78Apoptosis inducer 10
CAS:<p>Apoptosis inducer 10 is a potent apoptosis inducer with anti-proliferative activity.</p>Fórmula:C27H46N2O2Forma y color:SolidPeso molecular:430.67Ac-IETD-CHO
CAS:<p>Ac-IETD-CHO is a potent, reversible inhibitor of granzyme B and caspase 8, which also impedes Fas-mediated apoptosis, hemorrhagic conditions, and liver failure.</p>Fórmula:C21H34N4O10Pureza:98%Forma y color:SolidPeso molecular:502.52PARP1/BRD4-IN-1
CAS:<p>PARP1/BRD4-IN-1 selectively inhibits PARP1 (49 nM IC50) and BRD4 (202 nM IC50), hindering pancreatic cancer cell growth.</p>Fórmula:C29H26N6O3Forma y color:SolidPeso molecular:506.56Antitumor agent-115
CAS:<p>Antitumor agent-115 (SS-12) is a potent anti-tumor compound, exhibiting an IC50 range of 0.34 μM-24.14 μM against the 4T1 mouse breast cancer cell line.</p>Fórmula:C19H38ClNO2Pureza:98%Forma y color:SolidPeso molecular:347.96HDAC8-IN-3
CAS:<p>HDAC8-IN-3 (P19) inhibits HDAC8 (IC50 9.3 μM), induces leukemic cell apoptosis, and enhances thermal stability.</p>Fórmula:C18H12N4O3S2Forma y color:SolidPeso molecular:396.44NVS-CECR2-1
CAS:<p>NVS-CECR2-1 is a CECR2 inhibitor with anti-tumor activity that inhibits chromatin binding of the CECR2 BRD.</p>Fórmula:C27H37N5O2SPureza:98.68%Forma y color:SolidPeso molecular:495.68CAM 833
CAS:<p>CAM 833 inhibits BRCA2-RAD51 interaction; Kd for ChimRAD51 is 366 nM, disrupts RAD51 oligocoagulation, and induces apoptosis in G2/M cells.</p>Fórmula:C26H26ClFN4O5Pureza:99.83%Forma y color:SolidPeso molecular:528.96Propiomazine
CAS:<p>Propiomazine is an orally active antihistamine compound with sedative properties, useful for controlling insomnia in neurological disorders.</p>Fórmula:C20H24N2OSPureza:98.5%Forma y color:SolidPeso molecular:340.48EGFR-IN-51
CAS:<p>EGFR-IN-51 effectively inhibits EGFR and mutations with IC50s of 0.493-461.63 μM; it induces apoptosis in cancer cells.</p>Fórmula:C21H15N3O2SForma y color:SolidPeso molecular:373.43Tubulin polymerization-IN-26
CAS:<p>Tubulin-IN-26 blocks microtubule formation at colchicine site; IC50 4.64μM; may help in lung cancer study.</p>Fórmula:C25H23N3O2Forma y color:SolidPeso molecular:397.47Apogossypolone (ApoG2)
CAS:<p>Apogossypolone (ApoG2) is a semi-synthesized derivative of gossypol which is a nonpeptidic small molecule inhibitor targeting Bcl-2 family proteins with K i</p>Fórmula:C28H26O8Forma y color:SolidPeso molecular:490.5MI-389
CAS:<p>MI-389 is a PROTAC degrader that induces the degradation of receptor tyrosine kinases (RTKs), useful for leukemia research.</p>Fórmula:C35H35FN6O6Pureza:98.12%Forma y color:SolidPeso molecular:654.69Sparfosic Acid
CAS:<p>Sparfosic Acid (Acide sparfosique) is an aspartate carbamoyltransferase inhibitor with antitumor activity and can be used to study advanced renal cell carcinoma</p>Fórmula:C6H10NO8PPureza:98.89%Forma y color:SolidPeso molecular:255.12Tubulin polymerization-IN-31
CAS:<p>Compound 4c, inhibits tubulin polymerization, IC50 3.64 μM, and induces cancer cell apoptosis.</p>Fórmula:C18H13ClFN3Forma y color:SolidPeso molecular:325.77RIP1 kinase inhibitor 5
CAS:<p>RIP1 kinase inhibitor 5 (example 1) serves as a potent regulator of tumor immunity by inhibiting RIP1, functioning similarly to SIR1-365 (compound 13) in</p>Fórmula:C13H17F2NO2Pureza:98%Forma y color:SolidPeso molecular:257.28GLUT4-IN-2
CAS:<p>GLUT4-IN-2, selective GLUT4 blocker; IC50: 6.8μM (GLUT4), 11.4μM (GLUT1). Induces apoptosis, G0/G1 arrest, has antitumor effects.</p>Fórmula:C17H11N3O4S2Pureza:99.90%Forma y color:SolidPeso molecular:385.42BMH-7
CAS:<p>BMH-7 (Histamine H4 receptor antagonist-2) is a p53 activator, demonstrating anti-cancer activity by activating the p53 pathway.</p>Fórmula:C20H21N5OPureza:99.71%Forma y color:SolidPeso molecular:347.413-(3-Phenoxybenzyl)amino-β-carboline
CAS:<p>3-(3-Phenoxybenzyl)amino-β-carboline is a highly effective tubulin inhibitor, selectively degrading αβ-tubulin heterodimers.</p>Fórmula:C24H19N3OForma y color:SolidPeso molecular:365.43Sibiriline
CAS:<p>Sibiriline is a Receptor-Interacting Protein Kinase 1 inhibitor that acts by preventing immune-dependent hepatitis.</p>Fórmula:C13H10N2OPureza:98%Forma y color:SolidPeso molecular:210.23CK2/ERK8-IN-1
CAS:<p>TMCB inhibits CK2 (Ki: 0.25 µM), ERK8 (IC50: 0.50 µM), PIM1, DYRK1A, HIPK2 (Ki: 8.65-15.25 µM), and induces apoptosis.</p>Fórmula:C11H9Br4N3O2Pureza:98.22%Forma y color:SolidPeso molecular:534.82RIPK1-IN-11
CAS:<p>RIPK1-IN-11, an oral RIPK1 blocker, Kd 9.2 nM, IC50 67 nM, prevents necrosis and inflammation in cells.</p>Fórmula:C23H24N4O4SForma y color:SolidPeso molecular:452.53RS6212
CAS:<p>RS6212 is a specific lactate dehydrogenase (LDH) inhibitor (IC50=12.03 μ M）。 RS6212 shows strong anticancer activity in a variety of cancer cell lines.</p>Fórmula:C20H22N4O3SForma y color:SolidPeso molecular:398.48RIP1 kinase inhibitor 7
CAS:<p>RIP1 Kinase Inhibitor 7 (Compound 41) serves as a potent inhibitory agent for receptor interacting protein 1 kinase (RIP1) with an IC50 of under 100 nM.</p>Fórmula:C20H20FN3OPureza:98%Forma y color:SolidPeso molecular:337.39UCB-6876
CAS:<p>UCB-6876 inhibits TNF signaling, stabilizes trimer asymmetry, shows concentration response, and is selective for TNFR1.</p>Fórmula:C17H18N2OForma y color:SolidPeso molecular:266.34CTX1
CAS:<p>CTX1 is a small molecule activator of p53.</p>Fórmula:C14H10N4Pureza:98%Forma y color:SolidPeso molecular:234.26Darinaparsin
CAS:<p>Darinaparsin, a dimethylated arsenic-glutathione compound, is cytotoxic to various cancer cells with diverse IC50 values and inhibits tumor growth in mice.</p>Fórmula:C12H22AsN3O6SForma y color:SolidPeso molecular:411.31RET-IN-6
CAS:<p>RET-IN-6 is a potent inhibitor of RET (IC50: 4.57 nM).</p>Fórmula:C30H29N7Forma y color:SolidPeso molecular:487.6(R)-STU104
CAS:<p>(R)-STU104 is a TAK1-MKK3 protein-protein interaction (PPI) inhibitor. (R)-STU104 is a candidate compound for the treatment of ulcerative colitis.</p>Fórmula:C18H18O4Pureza:98.91% - 99.42%Forma y color:SolidPeso molecular:298.33Flunisolide hemihydrate
CAS:<p>Flunisolide hemihydrate, a corticosteroid with anti-inflammatory properties, treats asthma and rhinitis by inducing eosinophil apoptosis.</p>Fórmula:C48H64F2O13Forma y color:SolidPeso molecular:887.024STAT3-IN-11
CAS:<p>STAT3-IN-11 is a STAT3 inhibitor.STAT3-IN-11 promotes apoptosis in cancer cells and is a candidate compound for the treatment of cancer.</p>Fórmula:C20H17NO4Pureza:98.3%Forma y color:SolidPeso molecular:335.35L6H21
CAS:<p>L6H21 is an MD-2 inhibitor that can be used to study cognitive impairment and brain damage.</p>Fórmula:C18H18O4Pureza:99.26%Forma y color:SolidPeso molecular:298.33DAT-230
CAS:<p>DAT-230 is a microtubule inhibitor effective against cancer cells, causing cell cycle arrest and apoptosis via caspase activation.</p>Fórmula:C20H21NO2SForma y color:SolidPeso molecular:339.45DB1976
CAS:<p>DB1976: Selenophene DB270 analog, inhibits PU.1 (IC50=10 nM), disrupts PU.1/DNA (KD=12 nM), induces apoptosis, cell-permeable.</p>Fórmula:C20H16N8SePureza:98.74%Forma y color:SolidPeso molecular:447.35SCFSkp2-IN-2
CAS:<p>SCFSkp2-IN-2, a Skp2 inhibitor, exhibits a dissociation constant (K_D) of 28.77 μM.</p>Fórmula:C17H20N4O2Pureza:99.86%Forma y color:SolidPeso molecular:312.37Deferitazole
CAS:<p>Deferitazole (FBS 0701) is a novel and orally active, selective and high affinity iron chelator.</p>Fórmula:C18H25NO7SPureza:99.48%Forma y color:SolidPeso molecular:399.46XX-650-23
CAS:<p>XX-650-23 is a CREB inhibitor that induces apoptosis and cell cycle arrest in AML cells and can be used to study acute myeloid leukemia (AML).</p>Fórmula:C18H12N2O2Pureza:97.01%Forma y color:SolidPeso molecular:288.3DX3-213B
CAS:<p>DX3-213B is a potent, orally active inhibitor of oxidative phosphorylation (OXPHOS) complex I with an IC50 of 3.6 nM.</p>Fórmula:C20H28F2N2O5S2Pureza:99.85%Forma y color:SolidPeso molecular:478.57cRIPGBM chloride
CAS:<p>cRIPGBM chloride is a pro-apoptotic derivative found in GBM cancer stem cells with anti-tumor activity, inducing caspase-1-dependent apoptosis.</p>Fórmula:C26H20ClFN2O2Pureza:99.75%Forma y color:SolidPeso molecular:446.9Ro 90-7501
CAS:<p>Ro 90-7501, an amyloid β42 (Aβ42) protofibril and TPR-dependent PP5 inhibitor, is a novel cervical cancer cell radiosensitizer that inhibits HCMV.</p>Fórmula:C20H16N6Pureza:97.21% - 99.72%Forma y color:SolidPeso molecular:340.38Stemazole
CAS:<p>Stemazole activates human stem cell growth, boosts survival, reduces cell death, and aids myelin repair, with therapeutic potential in demyelinating diseases.</p>Fórmula:C9H9N5OS2Pureza:98.57%Forma y color:SolidPeso molecular:267.33RIPK3-IN-1
CAS:<p>RIPK3-IN-1 is a RIPK3 inhibitor (IC50: 9.1 nM) that inhibits c-Met kinase, RIPK1, and RIPK2 activity and can be used to study apoptosis.</p>Fórmula:C29H25FN4O4Pureza:98.27%Forma y color:SolidPeso molecular:512.53Ciglitazone
CAS:<p>Ciglitazone: potent PPARγ agonist, EC50 3 μM, oral hypoglycemic; reduces insulin, blood pressure, Th17 cells, VEGF; halts gastric cancer growth.</p>Fórmula:C18H23NO3SPureza:98.23% - 99.59%Forma y color:White Cyrstalline SolidPeso molecular:333.45SLMP53-1
CAS:<p>SLMP53-1 is a p53 activator with anti-tumor activity, activates reprogramming of glucose metabolism, and interferes with angiogenesis and migration</p>Fórmula:C20H18N2O2Pureza:99.64%Forma y color:SolidPeso molecular:318.37T025
CAS:<p>T025 inhibits CLK1-4 (Kds: 0.074-6.5 nM), shows anti-cancer effects (IC50: 30-300 nM), useful for MYC-related disease research.</p>Fórmula:C21H18N8Pureza:98.08%Forma y color:SolidPeso molecular:382.42AMG PERK 44
CAS:<p>AMG PERK 44 is a PERK inhibitor that induces autophagy.AMG PERK 44 inhibits GCN2 and B-Raf and can be used in cancer research.</p>Fórmula:C34H29ClN4O2Pureza:98.8% - 99.81%Forma y color:SolidPeso molecular:561.07Tubulin inhibitor 11
CAS:<p>Potent, oral Tubulin inhibitor 11 hinders polymerization, targets Colchicine site, induces mitotic block, and apoptosis.</p>Fórmula:C22H23N3O3SPureza:98.32%Forma y color:SoildPeso molecular:409.5FA16
<p>FA16 is a selective, metabolically stable ferroptosis inducer with an IC50 value of 1.26 μM.FA16 is a derivative of 2-(trifluoromethyl)benzimidazole.FA16</p>Fórmula:C22H27F3N4O2SPureza:99.44%Forma y color:SolidPeso molecular:468.54CMLD-2
CAS:<p>CMLD-2 is a HuR-ARE inhibitor (Ki: 350 nM) that promotes apoptosis, has antitumor properties, and reduces thyroid cancer cell viability.</p>Fórmula:C31H31NO6Pureza:99.99%Forma y color:SolidPeso molecular:513.58Sabizabulin
CAS:<p>Sabizabulin (ABI-231) is a potent, orally bioavailable α- and β-tubulin inhibitor.Cost-effective and quality-assured.</p>Fórmula:C21H19N3O4Pureza:98.10% - 99.79%Forma y color:SolidPeso molecular:377.39NM-3
CAS:<p>NM-3, an oral anti-angiogenic and anti-tumor agent, modulates radiation and blocks VEGF to curb endothelial growth and induce apoptosis.</p>Fórmula:C13H12O6Pureza:99.89%Forma y color:SolidPeso molecular:264.23GSK854
CAS:<p>GSK854 is a selective TNNI3K inhibitor reducing heart damage and stress post-infarction in mice.</p>Fórmula:C18H19ClN6O4S2Pureza:98.79%Forma y color:SolidPeso molecular:482.96K-8012
CAS:<p>K-8012 is a modulator of the N-terminally truncated RXRα and improves anticancer activities in an RXRα-dependent manner.</p>Fórmula:C23H23FN4Pureza:99.72%Forma y color:SolidPeso molecular:374.45KR-33493
CAS:<p>KR-33493 is a FAS-associated factor 1 (FAF1) inhibitor and can be used in studies about Parkinson's disease.</p>Fórmula:C20H18BrN3O3SPureza:99.96%Forma y color:SolidPeso molecular:460.34HBED
CAS:<p>HBED (CHELII) is an iron chelator and can be used in research on the treatment of chronic iron overload and acute iron poisoning.</p>Fórmula:C20H24N2O6Pureza:97.35% - 98.58%Forma y color:SolidPeso molecular:388.41EM-12
CAS:<p>EM-12, a Thalidomide analogue, is more active, stable, and boosts rat colon cancer studies.</p>Fórmula:C13H12N2O3Pureza:99.34%Forma y color:SolidPeso molecular:244.25TAI-1
CAS:<p>TAI-1 is a potent and specific Hec1 inhibitor, which disrupts Hec1-Nek2 protein interaction.</p>Fórmula:C24H21N3O3SPureza:99.58%Forma y color:SolidPeso molecular:431.51Tiomolibdate diammonium
CAS:<p>Tiomolibdate diammonium (NSC-286644) blocks SOD1 and COX, acting as an antiangiogenic and antitumor agent.</p>Fórmula:H8MoN2S4Pureza:98%Forma y color:Brown To Black Iridescent Crystalline PowderPeso molecular:260.28MBM-55
CAS:<p>MBM-55 is an effective inhibitor of NIMA related kinase 2 (NEK2) with an IC50 of 1 nM.</p>Fórmula:C28H27FN6O2Pureza:99.83%Forma y color:SolidPeso molecular:498.55Etomoxir
CAS:<p>Etomoxir is an irreversible inhibitor of carnitine palmitoyltransferase 1a (CPT-1a) (IC50=5-20 nM), inhibits fatty acid oxidation. High-Quality, Low-Cost!</p>Fórmula:C17H23ClO4Pureza:98% - 99.39%Forma y color:SolidPeso molecular:326.82Necrostatin-5
CAS:<p>Necrostatin-5 (Nec-5) inhibits RIP1 kinase, prevents cell necrosis, and protects Fadd-deficient Jurkat cells with an EC50 of 240 nM.</p>Fórmula:C19H17N3O2S2Pureza:98.03%Forma y color:SolidPeso molecular:383.49CTA 056
CAS:<p>CTA 056 is an ITK inhibitor that inhibits the growth of MOLT-4 xenograft tumors in mice and can be used to study autoimmune disorders.</p>Fórmula:C35H34N6OPureza:97.22% - 97.76%Forma y color:SolidPeso molecular:554.68RS1-PDK1 inhibitor
CAS:<p>RS1-PDK1 inhibitor (RS 1) is a selective inhibitor of the protein kinase PDK1 that can be used to treat and prevent disease or disorders.</p>Fórmula:C15H9ClN2O2S3Pureza:98.12%Forma y color:SolidPeso molecular:380.89HS38
CAS:<p>HS38: DAPK-specific ATP-competitive inhibitor; Kds: DAPK1 (300 nM), PIM3 (200 nM), ZIPK (280 nM); useful in smooth muscle disorder research.</p>Fórmula:C14H12ClN5O2SPureza:98.19%Forma y color:SolidPeso molecular:349.8Bomedemstat ditosylate
CAS:<p>Bomedemstat (IMG-7289) is an LSD1 inhibitor for acute myeloid leukemia, MDS, and Myelofibrosis; induces apoptosis by regulating p53, PUMA, and BCLXL.</p>Fórmula:C42H50FN7O8S2Pureza:99.05%Forma y color:SolidPeso molecular:864.02Erastin2
CAS:<p>Erastin2 is an iron death inducer that induces cell death by binding to the lipophilic free radical trapping antioxidant ferrostatin-1 or the iron chelator DFO.</p>Fórmula:C36H35ClN4O4Pureza:99.63%Forma y color:SolidPeso molecular:623.14CP 461
CAS:<p>CP 461 is a PDE2A inhibitor that promotes apoptosis in cancer cells without affecting normal cells or COX-1/2.</p>Fórmula:C25H22ClFN2OPureza:99.82%Forma y color:SolidPeso molecular:420.91P505-15 Acetate
CAS:<p>P505-15 Acetate inhibits spleen tyrosine kinase, reduces immune response and inflammation, and lowers arthritis severity.</p>Fórmula:C21H27N9O3Pureza:99.99%Forma y color:SolidPeso molecular:453.5MMRi64
CAS:<p>MMRi64 inhibits Mdm2-MdmX, boosts p53, triggers apoptosis, and is used in cancer research.</p>Fórmula:C22H17Cl2N3OPureza:99.93%Forma y color:SolidPeso molecular:410.3GSK-3β inhibitor 3
CAS:<p>GSK-3β inhibitor 3 is a covalent inhibitor (IC50: 6.6 μM) of glycogen synthase kinase 3β (GSK-3β) that is potent, selective, and irreversible.GSK-3β inhibitor 3</p>Fórmula:C18H14FNO2SPureza:97.53%Forma y color:SolidPeso molecular:327.37NecroX-7
CAS:<p>NecroX-7 (LC-280126) is a potent free radical scavenger and a HMGB1 (high-mobility group box 1) inhibitor.</p>Fórmula:C24H29N3O3SPureza:98.22%Forma y color:SolidPeso molecular:439.57HBDDE
CAS:<p>HBDDE inhibits PKCα/γ (IC50: 43/50 μM), favors them over PKCδ/βI/βII, and induces neuronal apoptosis. Derived from ellagic acid.</p>Fórmula:C16H18O8Pureza:97.94%Forma y color:SolidPeso molecular:338.31GSK2593074A
CAS:<p>GSK2593074A (GSK'074) is a programmed necrosis inhibitor that displays inhibitory effects on RIP1 and RIP3.</p>Fórmula:C27H23N5OSPureza:99.76%Forma y color:SolidPeso molecular:465.57AQ4
CAS:<p>AQ4 is a topoisomerase II inhibitor and DNA-inserting agent that inhibits proliferation and induces apoptosis in two cell lines.</p>Fórmula:C22H28N4O4Pureza:96.28% - 97.15%Forma y color:SolidPeso molecular:412.48MJN68390
CAS:<p>MJN68390 has an apparent IC50 value of 15 μM against CASP8 and shows no activity against CASP10.</p>Fórmula:C24H28ClN3O3Pureza:98.86%Forma y color:SolidPeso molecular:441.95PARP/PI3K-IN-1
CAS:PARP/PI3K-IN-1 is a PARP and PI3K dual inhibitor with anticancer and antiproliferative activities for the study of breast, pancreatic and lung cancers.Fórmula:C33H28F4N8O3Pureza:99.59%Forma y color:SolidPeso molecular:660.62CUDC-427
CAS:<p>CUDC-427 (GDC-0917) is an orally bioactive and pan antagonist of inhibitor of apoptosis proteins(IAPs). CUDC-427 can be used in research on cancers.</p>Fórmula:C29H36N6O4SPureza:99.92%Forma y color:SolidPeso molecular:564.7STAT3-IN-13
CAS:<p>STAT3-IN-13 is a STAT3 inhibitor with antiproliferative activity that induces apoptosis and can be used to study breast and liver cancer.</p>Fórmula:C21H20N6O3SPureza:98.89%Forma y color:SolidPeso molecular:436.49HS-276
CAS:<p>HS-276, a selective oral TAK1 inhibitor (Ki: 2.5 nM), also targets CLK2, GCK, ULK2, MAP4K5; potential for RA research.</p>Fórmula:C24H29N5O2Pureza:97.852% - 98.81%Forma y color:SolidPeso molecular:419.52TC-DAPK 6
CAS:<p>TC-DAPK 6 is an ATP-competitive inhibitor of Death-associated protein kinase (DAPK) with IC50s of 69 and 225 nM for DAPK1 and DAPK3.</p>Fórmula:C17H12N2O2Pureza:98.73%Forma y color:SolidPeso molecular:276.29Anticancer agent 110
CAS:<p>Anticancer Agent 110 exhibits potent in vitro anti-leukemia activity, demonstrating high cytotoxicity against K-562 lineage chronic myelogenous leukemia cells</p>Fórmula:C18H13FN6OSPureza:98%Forma y color:SolidPeso molecular:380.4Sarmustine
CAS:<p>SarCNU is an alkylating anticancer drug targeting prostate cancer through p53 pathways and selects P140K MGMT-transduced CD34(+) cells.</p>Fórmula:C6H11ClN4O3Pureza:98.29% - 99.71%Forma y color:SolidPeso molecular:222.63DK419
CAS:<p>DK419 is an orally active inhibitor of Wnt/β-catenin signaling, with an IC50 of 0.19 μM.</p>Fórmula:C16H8ClF6N3OPureza:99.63%Forma y color:SolidPeso molecular:407.7BCP-T.A
CAS:<p>BCP-T.A is an iron death inducer that acts by binding to GPX4.</p>Fórmula:C23H19Cl2N3OSPureza:99.49%Forma y color:SolidPeso molecular:456.39Dasatinib hydrochloride
CAS:<p>Dasatinib hydrochloride is an oral Src/Bcr-Abl inhibitor with potent antitumor effects, Ki values of 16 pM (Src) and 30 pM (Bcr-Abl).</p>Fórmula:C22H27Cl2N7O2SPureza:99.88% - 99.98%Forma y color:SolidPeso molecular:524.47NLRP3/AIM2-IN-3
CAS:<p>NLRP3/AIM2-IN-3 selectively blocks NLRP3/AIM2 inflammasomes; IC50 for cell lysis is 0.077 μM, disrupting ASC oligomerization.</p>Fórmula:C16H14N2O2Pureza:97.04%Forma y color:SolidPeso molecular:266.29BC 11 hydrobromide
CAS:<p>The compound is a selective urokinase inhibitor (IC50 = 8.2 μM). It also inhibits clot lysis with no effect on clot formation.</p>Fórmula:C8H12BBrN2O2SPureza:98.07%Forma y color:SolidPeso molecular:290.97CSN5i-3
CAS:<p>CSN5i-3 is a potent, selective, and orally available inhibitor of the proteolytic subunit of the CSN complex, CSN5, as an anticancer agent.Cost-effective and quality-assured.</p>Fórmula:C28H29F2N5O2Pureza:99.56% - >99.99%Forma y color:SolidPeso molecular:505.56RET-IN-23
CAS:<p>RET-IN-23 is an orally available and highly potent RET inhibitor with significant antitumor activity for the study of non-small cell lung cancer.</p>Fórmula:C28H28FN11Pureza:97.46%Forma y color:SolidPeso molecular:537.59TT01001
CAS:<p>TT01001, a mitoNEET agonist, may treat type II diabetes by reducing oxidative stress and preventing neuronal death.</p>Fórmula:C15H19Cl2N3O2SPureza:99.93%Forma y color:SolidPeso molecular:376.3Minodronic acid
CAS:Minodronic acid (YM-529) is a P2X2/3 antagonist with anticancer properties, inhibiting cell growth and metastasis, and used in osteoporosis research.Fórmula:C9H12N2O7P2Pureza:98.02%Forma y color:SolidPeso molecular:322.15W146
CAS:<p>W146 is an S1PR1 antagonist that induces a significant but transient decrease in blood lymphocytes in mice.</p>Fórmula:C16H27N2O4PPureza:99.37%Forma y color:SolidPeso molecular:342.37GCN2-IN-1
CAS:<p>GCN2-IN-1 (A-92) is an effective GCN2 inhibitor and can be used in research on the treatment of cancer as a chemotherapeutic agent.</p>Fórmula:C19H18N10OPureza:99.49% - 99.64%Forma y color:SolidPeso molecular:402.41Brigimadlin
CAS:<p>Brigimadlin (BI 907828) is an orally active and highly potent antagonist of the E3 ubiquitin-protein ligase MDM2-p53 with antitumor activity.</p>Fórmula:C31H25Cl2FN4O3Pureza:98.17%Forma y color:SolidPeso molecular:591.46Apostatin-1
CAS:<p>Apostatin-1 (Apt-1) is a novel TRADD inhibitor. Apostatin-1 can bind to a pocket on the N-terminal TRAF2 binding domain of TRADD.</p>Fórmula:C19H27N3OSPureza:99.31%Forma y color:SolidPeso molecular:345.5Vamotinib
CAS:<p>Vamotinib (PF-114) is a tyrosine kinase inhibitor with antiproliferative and antitumor activity.Vamotinib is used in the study of Alzheimer's disease.</p>Fórmula:C29H27F3N6OPureza:99.64%Forma y color:SolidPeso molecular:532.56SB 699551 dihydrochloride
CAS:<p>SB 699551 dihydrochloride is a 5-ht5a receptor antagonist.</p>Fórmula:C34H47Cl2N3OPureza:99.83%Forma y color:SolidPeso molecular:584.66Trk-IN-9
CAS:<p>Trk-IN-9 is a TRK inhibitor with anticancer and antiproliferative activity and can be used in cancer research.</p>Fórmula:C23H24ClFN6OPureza:98.15%Forma y color:SolidPeso molecular:454.93Prinomastat
CAS:<p>Prinomastat: orally active, crosses blood-brain barrier, inhibits MMP-1/2/3/9, Ki/IC50s: 0.05-0.3/5.0-79 nM, antitumor.</p>Fórmula:C18H21N3O5S2Pureza:99.23%Forma y color:SolidPeso molecular:423.51AZA1
CAS:<p>AZA1 (Rac1/Cdc42-IN-1) is a potent dual inhibitor of Rac1 and Cdc42.</p>Fórmula:C22H20N6Pureza:99.75%Forma y color:SolidPeso molecular:368.43eIF4A3-IN-1
CAS:<p>eIF4A3-IN-1 is an inhibitor of eukaryotic initiation factor 4A3 (eIF4A3). eIF4A3-IN-1 inhibits cytosolic nonsense-mediated RNA decay at high concentrations.</p>Fórmula:C29H23BrClN5O2Pureza:99.49% - 99.89%Forma y color:SolidPeso molecular:588.88AOH1160
CAS:<p>AOH1160 is an inhibitor of proliferating cell nuclear antigen (PCNA).</p>Fórmula:C25H20N2O3Pureza:98.46% - 99.52%Forma y color:SolidPeso molecular:396.44Imipramine
CAS:<p>Imipramine (Dimipressin) is a Fascin1 inhibitor with antitumor activity and induces apoptosis.</p>Fórmula:C19H24N2Pureza:99.4%Forma y color:White To Off-White /Hydrochloride/ SolidPeso molecular:280.41ZDLD20
CAS:<p>ZDLD20 is a CDK4 inhibitor with anti-HCT116 and anticancer activity that inhibits colony formation and blocks the G1 phase of the cell cycle.</p>Fórmula:C22H22N6OPureza:98.59%Forma y color:SolidPeso molecular:386.45UNC0321
CAS:<p>UNC0321 is an effective inhibitor of histone methyltransferase G9a with a Ki of 63 pM and with IC50s 9 nM and 6 nM in ECSD and CLOT assays.</p>Fórmula:C27H45N7O3Pureza:99.80%Forma y color:SolidPeso molecular:515.69Antifolate C2
CAS:<p>Antifolate C2 (AGF 154) inhibits tumor growth with 0.14 nM IC, useful in cancer/autoimmune research.</p>Fórmula:C19H21N5O6SPureza:99.57%Forma y color:SolidPeso molecular:447.46D609
CAS:<p>D609 (Tricyclodecan-9-yl-Xanthogenate) has antiviral and antiproliferative activities.D609 acts through competitive inhibition of PC, PC-P and SMS.</p>Fórmula:C11H15KOS2Pureza:97.67% - 99.56%Forma y color:Off-White PowderPeso molecular:266.46TL4-12
CAS:<p>TL4-12 is a MAP4K2 (GCK) inhibitor that inhibits IL-1 and TGFβ-induced p38 MAPK phosphorylation in vitro.</p>Fórmula:C25H27F3N6O2Pureza:98.38%Forma y color:SolidPeso molecular:500.52BCL6-IN-7
CAS:<p>BCL6-IN-7 (BCL6 inhibitor-7) is a BCL6 corepressor-interaction inhibitor with potential antitumor activity, used in lymphoma research.</p>Fórmula:C18H15ClN6OPureza:99.03%Forma y color:SolidPeso molecular:366.8UC-112
CAS:<p>UC-112 is a novel potent IAP inhibitor and potently inhibits cell growth in two human melanoma and two human prostate cancer cell lines (IC50=0.7-3.4 uM).</p>Fórmula:C22H24N2O2Pureza:99.54%Forma y color:SolidPeso molecular:348.44C6 Ceramide
CAS:<p>C6 Ceramide (N-hexanoylsphingosine) is an activator of the ceramide pathway that arrests cells in the G0/G1 phase by activating ERK.</p>Fórmula:C24H47NO3Pureza:99.67%Forma y color:SolidPeso molecular:397.63A 419259 trihydrochloride
CAS:A 419259 trihydrochloride (RK 20449 trihydrochloride) is an Src family kinases inhibitor (IC50s: 9 nM, 3 nM and 3 nM for Src, Lck and Lyn).Fórmula:C29H37Cl3N6OPureza:99.75% - 99.96%Forma y color:SolidPeso molecular:592F16
CAS:<p>F16 ((E)-4-(3-indolylvinyl)-N-methylpyridinium iodide) inhibits the growth of neu-overexpressing cells and the proliferation of mammary epithelial.</p>Fórmula:C16H15IN2Pureza:99.89%Forma y color:SolidPeso molecular:362.21Tubulin inhibitor 32
CAS:<p>Tubulin inhibitor 32 is a microtubule inhibitor with antiproliferative and antitumor activity that induces apoptosis and cell cycle arrest in the G2/M phase.</p>Fórmula:C18H19N3O3Pureza:99.92%Forma y color:SolidPeso molecular:325.36Pyrazoloacridine
CAS:<p>Pyrazoloacridine (PD 115934) binds DNA, inhibits topo I/II, has 1.25 μM IC50 in K562 cells, and exhibits anti-cancer effects.</p>Fórmula:C19H21N5O3Pureza:99.72%Forma y color:SolidPeso molecular:367.4JY-2
CAS:<p>JY-2 is a forkhead transcription factor O1 (FoxO1) inhibitor with antidiabetic activity that inhibits FoxO1 transcription and can be used to study psoriasis.</p>Fórmula:C13H7Cl2N3OPureza:99.66%Forma y color:SolidPeso molecular:292.12R306465
CAS:<p>R306465 (JNJ-16241199) is an HDAC 1 inhibitor with broad-spectrum anti-tumor activity, inducing apoptosis, and can be used to study solid tumors.</p>Fórmula:C19H19N5O4SPureza:98.46% - 99.54%Forma y color:SolidPeso molecular:413.45EGFR-IN-11
CAS:<p>EGFR-IN-11 selectively blocks EGFR-tyrosine kinase and promotes apoptosis; targets EGFRL858R/T790M/C797S, IC50=18 nM; halts cell cycle at G0/G1.</p>Fórmula:C29H35N9O2SPureza:99.93%Forma y color:SolidPeso molecular:573.71Droloxifene
CAS:<p>Droloxifene, a tamoxifen derivative and oral SERM, induces p53 and apoptosis; Fluroxifene protects bone, blocks estrogen and implantation.</p>Fórmula:C26H29NO2Pureza:99.86% - 99.97%Forma y color:Solid PowderPeso molecular:387.51GS-9191
CAS:<p>GS-9191 is a potent inhibitor of DNA polymerase alpha and ß , a prodrug of the novel nucleoside analogue 9-(2-phosphonomethoxyethyl)guanine (PMEG) , which</p>Fórmula:C37H51N8O6PPureza:98.01 - 99.28%Forma y color:SolidPeso molecular:734.82VAS 3947
CAS:<p>VAS 3947: NOX inhibitor, induces platelet apoptosis via UPR, not linked to NOX inhibition.</p>Fórmula:C14H10N6OSPureza:98.44%Forma y color:SolidPeso molecular:310.33LDCA
CAS:<p>LDCA inhibits LDH-A, disrupts mitochondrial function, induces apoptosis in cancer cells, and is non-toxic.</p>Fórmula:C8H5Cl3FNOPureza:98.99%Forma y color:SolidPeso molecular:256.49Gallium maltolate
CAS:<p>Gallium maltolate is a ribonucleoside-diphosphate reductase inhibitor.</p>Fórmula:C18H15GaO9Pureza:99.61% - 99.67%Forma y color:SolidPeso molecular:445.03TNIK-IN-3
CAS:<p>TNIK-IN-3 is a highly potent and orally active inhibitor of Traf2- and Nck-interacting protein kinase (TNIK).</p>Fórmula:C23H18FN3O2Pureza:98.39%Forma y color:SolidPeso molecular:387.41Triciribine phosphate
CAS:<p>Triciribine phosphate (VD 002) is an AKT inhibitor that inhibits neovascularization and can be used in the study of leukemia.</p>Fórmula:C13H17N6O7PPureza:97.94%Forma y color:SolidPeso molecular:400.28Cot inhibitor-1
CAS:<p>Cot inhibitor-1 selectively blocks Tpl2 kinase, reducing TNF-alpha in blood (IC50: 5.7 nM). It may treat arthritis, IBD, and certain cancers.</p>Fórmula:C27H27Cl2FN8Pureza:98.59%Forma y color:SolidPeso molecular:553.46Atrosab
CAS:<p>Atrosab is a humanized IgG1 antibody targeting TNFR1, inhibiting TNF-mediated apoptosis, and can be used to study inflammatory and neurodegenerative diseases.</p>Pureza:SDS-PAGE:>95%;SEC-HPLC:95.22%Forma y color:LiquidPeso molecular:146.12 kDa
